Number of Shares
229,000.00
Current Holdings Value*
HK$3.47 Mil
% of Portfolio
4.49%
Total Estimate Gain
HK$3.37 Mil
% of Total Estimate Gain
33.42%

Aberdeen Global Equity Impact Fund's WuXi Biologics (Cayman) Inc Holding Summary

As of 2021-10-31, Aberdeen Global Equity Impact Fund held 229,000.00 shares of WuXi Biologics (Cayman) Inc(HKSE:02269), totaling HK$3.47 Mil. This investment constitutes 4.49% of their stock portfolio, and Aberdeen Global Equity Impact Fund now holds 0.01% of the outstanding WuXi Biologics (Cayman) Inc(HKSE:02269) stock.

The initial trade took place in 2019Q4. And since then Aberdeen Global Equity Impact Fund has made 2 purchases of HKSE:02269, at an average price of HK$31.90, for a total of 316,500.00 shares. In addition, there have been 3 sales at an average price of HK$78.69 for 87,500.00 shares. Based on historical transaction data and HKSE:02269's current price of HK$28.75, Aberdeen Global Equity Impact Fund's estimated gain on his HKSE:02269 holdings is HK$3.37 Mil, reflecting a 33.42% gain to date.

Aberdeen Global Equity Impact Fund HKSE:02269 (HK$28.75) Holding Chart

Aberdeen Global Equity Impact Fund HKSE:02269 (HK$28.75) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price HK$-/Share
Shares Sold 0 Average Price HK$-/Share
Current Price HK$0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1